ArticleCell death & disease2020

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma.

Fei Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.